Literature DB >> 31585098

Optimization of an enzyme-coupling method by spectrophotometer for serum adenosine deaminase: As a candidate reference method.

Liqiao Han1, Xiaoting Huang1, Jianbing Wang1, Haibiao Lin1, Qiaoxuan Zhang1, Yongmei Gu2, Keqi Sun3, Yongdan Yang4, Jun Yan1, Peifeng Ke1, Xianzhang Huang5, Junhua Zhuang6.   

Abstract

Adenosine deaminase (ADA) is a key enzyme of adenosine metabolism. There are currently various kits and systems available for ADA measurement, and all yield variable results. This study optimized a reference measurement procedure (RMP) for serum ADA for the standardization of routine methods. ADA coupled with purine-nucleoside-phosphorylase, xanthine-oxidase and peroxidase was selected as the basic method and was optimized using Response Surface Methodology. Then the performance was validated and the results were compared after replication by 3 other reference laboratories. A reference interval was also developed. In addition, this optimized method was applied to calibrate a routine system. The intra-assay precision was 0.44% at both concentrations of 29.8 and 100.4 U/L, and inter-assay precision was 1.01% and 0.95% at 30.1 and 100.3 U/L, respectively. The linearity was up to 351.9 U/L (R2 = 0.9998), with no significant interference or carryover (<5%). A Comparison among 4 reference laboratories showed good reproducibility (R2 ≥ 0.9975). The procedure proved valid for a reference interval of 11.7-38.5 U/L. The mean relative deviation for a routine system was -55.9% and -3.7% before and after calibration. This candidate RMP for serum ADA can potentially be used for standardization of clinical systems.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenosine deaminase (ADA); Candidate reference measurement procedure; Clinical laboratory; Enzyme-coupling method; Standardization

Year:  2019        PMID: 31585098     DOI: 10.1016/j.ab.2019.113462

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  1 in total

1.  Pleural homocysteine for malignant pleural effusion: A prospective and double-blind diagnostic test accuracy study.

Authors:  Xi-Shan Cao; Wen Zhao; Xu-Hui Wen; Yu-Ling Han; Li Yan; Ting-Wang Jiang; Jin-Hong Huang; Hong Chen; Wen-Qi Zheng; Zhi-De Hu
Journal:  Thorac Cancer       Date:  2022-07-11       Impact factor: 3.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.